| P50 | author | Giuseppe Lippi | Q45791880 |
| | Elisa Ciceri | Q47421503 |
| | Alessandra Bossi | Q47503849 |
| | Giuseppe K Ricciardi | Q57035305 |
| | Maria Cristina Dechecchi | Q39976946 |
| P2093 | author name string | Francesco Sala | |
| | Albino Eccher | |
| | Raffaella Mariotti | |
| | Donatella Benati | |
| | Andrea Sbarbati | |
| | Giulio Cabrini | |
| | Anna Tamanini | |
| | Giampietro Pinna | |
| | Laura Belli | |
| | Gianfranco Di Gennaro | |
| | Ilaria Scambi | |
| | Silvia Munari | |
| | Alessandra Santangelo | |
| | Pietro Imbrucè | |
| | Beatrice Gardenghi | |
| | Rina Agushi | |
| P2860 | cites work | Analyzing the circulating microRNAs in exosomes/extracellular vesicles from serum or plasma by qRT-PCR. | Q41953389 |
| | A specific miRNA signature in the peripheral blood of glioblastoma patients | Q45256953 |
| | Plasma MicroRNA-21 concentration may be a useful biomarker in glioblastoma patients | Q48409555 |
| | Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles | Q48411865 |
| | Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab | Q48956083 |
| | Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma. | Q53624071 |
| | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 |
| | Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 |
| | MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 |
| | Isolation and characterization of exosomes from cell culture supernatants and biological fluids | Q29615035 |
| | Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas | Q31154294 |
| | Temozolomide: a milestone in neuro-oncology and beyond? | Q33372340 |
| | Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness | Q33911224 |
| | Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer | Q35550230 |
| | Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma | Q35788900 |
| | A method based on light scattering to estimate the concentration of virus particles without the need for virus particle standards | Q35804569 |
| | A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas | Q36091092 |
| | Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 |
| | Epidemiology and molecular pathology of glioma | Q36577353 |
| | miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma | Q36608190 |
| | The biology and function of exosomes in cancer | Q36737945 |
| | Versatile roles of extracellular vesicles in cancer | Q36737955 |
| | Glypican-1 identifies cancer exosomes and detects early pancreatic cancer | Q36781050 |
| | A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool | Q37641229 |
| | Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules | Q37708930 |
| | miR221/222 in cancer: their role in tumor progression and response to therapy | Q37955986 |
| | Emerging technologies in extracellular vesicle-based molecular diagnostics | Q38191663 |
| | Circulating microRNA biomarkers for glioma and predicting response to therapy. | Q38201683 |
| | miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients | Q38476677 |
| | Towards a molecular understanding of microRNA-mediated gene silencing | Q38528410 |
| | Circulating biomarkers for gliomas | Q38586617 |
| | Emerging circulating biomarkers in glioblastoma: promises and challenges. | Q38591062 |
| | miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma | Q38779883 |
| | The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 |
| | Prognostic role of microRNA-21 expression in gliomas: a meta-analysis | Q38929251 |
| | Emerging role of microRNA-21 in cancer | Q38971467 |
| | Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods | Q39378626 |
| | A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab | Q39616746 |
| P433 | issue | 1 | |
| P921 | main subject | microRNA | Q310899 |
| | biomarker | Q864574 |
| P304 | page(s) | 51-62 | |
| P577 | publication date | 2017-10-26 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker | |
| P478 | volume | 136 | |